Spots Global Cancer Trial Database for placebo
Every month we try and update this database with for placebo cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER) | NCT00473590 | Multiple Myelom... | Bevacizumab Bortezomib placebo | 18 Years - | Genentech, Inc. | |
| Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) | NCT02564380 | Metastatic Squa... | Pembrolizumab Placebo | 18 Years - | AIO-Studien-gGmbH | |
| Pyrotinib in Combination With Neoadjuvant Chemotherapy in HR+/HER2-, HER4 High Expression Breast Cancer Patients: A Phase II Trial | NCT04872985 | Breast Cancer Hormone-recepto... | Pyrotinib Epirubicin Doxorubicin Hyd... Cyclophosphamid... Docetaxel Nab paclitaxel Placebo | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma | NCT00434161 | Multiple Myelom... | Palifermin befo... Placebo Palifermin befo... | 18 Years - 70 Years | Swedish Orphan Biovitrum | |
| Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer | NCT05930938 | Squamous Cell C... | Xevinapant Placebo cetuximab IMRT | 18 Years - 79 Years | Groupe Oncologie Radiotherapie Tete et Cou | |
| Chloroquine for Glioblastoma. | NCT04772846 | Glioblastoma | Oral tablet Placebo | 18 Years - 70 Years | Egyptian Medical Syndicate | |
| Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma | NCT00110994 | Cancer Melanoma | Sorafenib (Nexa... Placebo Dacarbazine | 18 Years - | Bayer | |
| Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | NCT00459407 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... | defined green t... placebo immunohistochem... immunoenzyme te... laboratory biom... biopsy mass spectromet... high performanc... | 18 Years - | National Cancer Institute (NCI) | |
| Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) | NCT02953301 | Mycosis Fungoid... Sezary Syndrome Lymphoma, T-Cel... | resminostat Placebo | 18 Years - | 4SC AG | |
| Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions | NCT04364581 | Myoma;Uterus | Letrozole Placebo | 18 Years - 45 Years | Mansoura University | |
| A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma | NCT00434252 | Melanoma | bevacizumab carboplatin paclitaxel placebo | 18 Years - | Genentech, Inc. | |
| Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients | NCT00516269 | Breast Cancer Fatigue Gastrointestina... | Methylphenidate Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy | NCT02003599 | Radiotherapy; A... Breast Neoplasm... | Laser therapy Placebo | 30 Years - 70 Years | Universidade do Vale do Sapucai | |
| Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women | NCT01889199 | Polycystic Ovar... | Flutamide Placebo | 18 Years - 35 Years | University of California, Los Angeles | |
| Vitamin D and Mammographic Breast Density | NCT01747720 | Breast Cancer | Vitamin D3 Placebo | 18 Years - 55 Years | CHU de Quebec-Universite Laval | |
| Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer | NCT01800422 | Stage IA Breast... Stage IB Breast... Stage II Breast... | telapristone ac... placebo therapeutic con... laboratory biom... questionnaire a... | 18 Years - | Northwestern University | |
| A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids | NCT02301897 | Uterine Fibroid... | Telapristone Ac... Placebo | 18 Years - 47 Years | Repros Therapeutics Inc. | |
| RCT of CBD for Anxiety in Advanced Breast Cancer | NCT04482244 | Advanced Breast... Anxiety CBD | Cannabidiol Placebo | 18 Years - | Dana-Farber Cancer Institute | |
| Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia | NCT00611650 | Lung Cancer Precancerous Co... Tobacco Use Dis... | defined green t... placebo | 45 Years - 74 Years | British Columbia Cancer Agency | |
| Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer | NCT01642251 | Extensive Stage... Large Cell Lung... Neuroendocrine ... Small Cell Carc... Stage IV Non-Sm... | Cisplatin Etoposide Veliparib Placebo | 18 Years - | National Cancer Institute (NCI) | |
| A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome | NCT01513317 | Myelodysplastic... | Siltuximab Placebo Best supportive... | 18 Years - | Janssen Research & Development, LLC | |
| Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer | NCT05809895 | Triple Negative... | Ociperlimab Tislelizumab Paclitaxel Nab-paclitaxel Carboplatin Placebo Pembrolizumab Gemcitabine | 18 Years - | Novartis | |
| Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia | NCT04446052 | Adult Patients ... | GM-CSF priming Placebo | 56 Years - | Eastern Cooperative Oncology Group | |
| Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension | NCT04882241 | Gastric Cancer Gastroesophagea... | Pembrolizumab Placebo Cisplatin Capecitabine 5-fluorouracil Docetaxel Oxaliplatin Leucovorin | 18 Years - | Merck Sharp & Dohme LLC | |
| Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin | NCT01093690 | Cancer | metoclopramide placebo | 18 Years - | Mahidol University | |
| Adjuvant Aspirin Treatment for Colon Cancer Patients | NCT02467582 | Colon Cancer | Aspirin Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Efficacy of Diclofenac BCG Irrigations | NCT01542567 | Bladder Cancer | Abitren Placebo | 20 Years - 80 Years | Carmel Medical Center | |
| Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women | NCT05829629 | HPV Infection HPV-Related Cer... | FluBHPVE6E7 Placebo | 18 Years - 49 Years | BlueSky Immunotherapies GmbH | |
| Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary Syndrome | NCT01587378 | Pregnancy Polycystic Ovar... | Metformin placebo | 18 Years - 45 Years | Norwegian University of Science and Technology | |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy | NCT02062632 | Esophageal Carc... Hypopharyngeal ... Laryngeal Carci... Lymphoma Mesothelioma Metastatic Mali... Metastatic Mali... Metastatic Mali... Non-Small Cell ... Sarcoma Small Cell Lung... Thymic Carcinom... Thymoma Thyroid Gland C... | Doxepin Hydroch... Placebo Quality-of-Life... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL | NCT04404283 | Diffuse Large B... | Brentuximab ved... Rituximab Lenalidomide Placebo | 18 Years - | Seagen Inc. | |
| Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy | NCT04833426 | Prostatic Neopl... Hypogonadism Testosterone De... | Testosterone ge... Placebo | 18 Years - | Canisius-Wilhelmina Hospital | |
| Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer | NCT01560923 | Metastatic Pros... | Indoximod Sipuleucel-T Placebo | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Neuropathic Pain in Patients With Cancer | NCT00474916 | Neuropathic Pai... | KRN5500 Placebo | 18 Years - | DARA Therapeutics | |
| Candin for the Treatment of Common Warts | NCT05889845 | Common Warts (V... | Candin, Intrade... Placebo | 12 Years - | Nielsen BioSciences, Inc. | |
| COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma | NCT00603759 | Head and Neck C... | celecoxib placebo | 20 Years - | Tehran University of Medical Sciences | |
| Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV | NCT04210336 | HPV Infection Lesion Cervix | PAPILOCARE PLACEBO | 30 Years - 65 Years | Procare Health Iberia S.L. | |
| Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin | NCT01093690 | Cancer | metoclopramide placebo | 18 Years - | Mahidol University | |
| Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia | NCT01259713 | Invasive Fungal... | Liposomal ampho... Placebo | 18 Years - | Gilead Sciences | |
| Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy | NCT00688194 | Breast Cancer | anastrozole exemestane fulvestrant lapatinib ditos... letrozole placebo | 18 Years - | National Cancer Institute (NCI) | |
| Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer | NCT05809895 | Triple Negative... | Ociperlimab Tislelizumab Paclitaxel Nab-paclitaxel Carboplatin Placebo Pembrolizumab Gemcitabine | 18 Years - | Novartis | |
| Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients | NCT00628043 | Anemia | epoetin beta placebo | 20 Years - 79 Years | Chugai Pharmaceutical | |
| Impact of Prophylactic Octreotide to Pancreatic Exocrine Secretion | NCT02920567 | Periampullary T... | Octreotide Placebo | 19 Years - 80 Years | Saint Vincent's Hospital, Korea | |
| Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors | NCT04916249 | Cancer Remission | Tibetree Pain R... Placebo | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy | NCT05025826 | Metastatic Gast... | Phycocare Placebo | 18 Years - | Nantes University Hospital | |
| A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis | NCT00323518 | Oral Mucositis Stomatitis | velafermin placebo | 18 Years - | Celldex Therapeutics | |
| L-carnitine vs Placebo for the Treatment of Muscle Cramps After Imatinib in Gastrointestinal Stromal Tumors | NCT03426722 | Gastrointestina... | L-carnitine Placebo | 18 Years - | Asan Medical Center | |
| Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis | NCT01268280 | Myasthenia Grav... | Placebo 250 mg CK-20173... 500 mg CK-20173... | 18 Years - 80 Years | Cytokinetics | |
| Economic Analyses of the REDUCE Trial | NCT01337258 | Neoplasms, Pros... Benign Prostati... Cancer | Dutasteride Placebo | 50 Years - 75 Years | GlaxoSmithKline | |
| Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D | NCT04729296 | Diabetes Mellit... | Golimumab Placebo | 3 Years - 46 Years | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |
| Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. | NCT03540407 | Cervical Carcin... Cervical Carcin... Cervical Carcin... Endometrial Ade... Endometrial Ade... Endometrial Ade... | Oncoxin-Viusid® Placebo | 18 Years - 80 Years | Catalysis SL | |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer | NCT04677504 | Biliary Tract C... | Atezolizumab Bevacizumab Placebo Cisplatin Gemcitabine | 18 Years - | Hoffmann-La Roche | |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | NCT04068896 | Pancreatic Canc... Metastatic Cast... Bladder Cancer Melanoma Non-small Cell ... Colorectal Canc... Gastric Cancer Esophageal Canc... Ovarian Cancer Head Neck Squam... Prostate Cancer | NGM120 NGM120 NGM120 NGM120 NGM120 NGM120 Placebo | 18 Years - | NGM Biopharmaceuticals, Inc | |
| Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix) | NCT01532232 | Breast Cancer Tobacco Depende... | placebo varenicline | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris | NCT05254249 | Psoriasis Vulga... | Lactobacillus P... Placebo | 18 Years - 70 Years | Dr. Soetomo General Hospital | |
| Single Ascending Dose, First-in-Human Study on Safety, Tolerability and Pharmacokinetics of BAY1161116 | NCT03119077 | Polycystic Ovar... | BAY1161116 Placebo Itraconazole | 45 Years - 65 Years | Bayer | |
| Maintaining Suppression of Testosterone With Transdermal Estradiol Gel | NCT02349386 | Cancer of the P... | BHR-200 (0.36% ... Placebo | 18 Years - | BHR Pharma, LLC | |
| Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection | NCT00575185 | Infectious Mono... | Valomaciclovir placebo | 15 Years - | University of Minnesota | |
| Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy | NCT00960115 | Non-small Cell ... | Tecemotide (L-B... Single low dose... Placebo Saline | 20 Years - | Merck KGaA, Darmstadt, Germany | |
| Study of Ruxolitinib in Colorectal Cancer Patients | NCT02119676 | CRC (Colorectal... | Ruxolitinib Regorafenib Placebo | 18 Years - | Incyte Corporation | |
| Efficacy of a Spirulina Supplement for Amelioration of Benign ThYroid Nodules | NCT03535974 | Benign Thyroid ... | Preparation wit... Placebo | 18 Years - | Fundatia Bio-Forum | |
| the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma | NCT01717066 | Stage I Hepatoc... Stage II Hepato... | the ginsenoside... Placebo | 18 Years - 75 Years | Eastern Hepatobiliary Surgery Hospital | |
| Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer | NCT05794659 | Advanced Ovaria... | AST-201 Paclitaxel Carboplatin Placebo rhuGM-CSF(Granu... | 18 Years - | Aston Sci. Inc. | |
| A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC) | NCT02356991 | Non-Small Cell ... | Famitinib Placebo | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer | NCT02165605 | Breast Cancer | HylaCare Placebo | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study | NCT03881111 | Esophageal Neop... | Pembrolizumab Placebo Cisplatin 5-FU | 18 Years - | Merck Sharp & Dohme LLC | |
| Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases | NCT00079001 | Metastatic Canc... Prostate Cancer | zoledronic acid placebo androgen depriv... GnRH agonist Calcium supplem... Vitamin D | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes | NCT02562066 | Myasthenic Synd... | amifampridine p... Placebo | 2 Years - 70 Years | Catalyst Pharmaceuticals, Inc. | |
| Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) | NCT01469221 | Bladder Cancer | Apaziquone Placebo | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects | NCT05740475 | Pulmonary Fibro... Tumor | 9MW3811 injecti... Placebo | 18 Years - 55 Years | Mabwell (Shanghai) Bioscience Co., Ltd. | |
| Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease | NCT02760433 | Rheumatoid Arth... | Olokizumab Placebo | 18 Years - | R-Pharm | |
| A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma | NCT02919670 | Multiple Myelom... Non-Hodgkin's L... | Enterade Placebo Standard Suppor... | 18 Years - | Dana-Farber Cancer Institute | |
| Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation | NCT00189488 | Graft Versus Ho... Hematologic Mal... | Palifermin Placebo Conditioning Re... Allogeneic stem... Methotrexate | 18 Years - | Swedish Orphan Biovitrum | |
| A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis | NCT01325571 | Myasthenia Grav... | Tacrolimus caps... Placebo | 18 Years - 70 Years | Astellas Pharma Inc | |
| The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss | NCT00375505 | Breast Cancer | Zoledronic acid Placebo | 18 Years - | Novartis | |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer | NCT00393822 | Colon Cancer | palifermin placebo | 18 Years - | Amgen | |
| Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females | NCT02740790 | Human Papilloma... | HPV vaccine Placebo | 9 Years - 45 Years | Shanghai Zerun Biotechnology Co.,Ltd | |
| Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency | NCT03580239 | Prostate Cancer | Everolimus Placebo | 18 Years - 75 Years | Tianjin Medical University Second Hospital | |
| Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication | NCT01678027 | Gastric Cancer Helicobacter Py... Family Members | Placebo LAC triple ther... | 40 Years - 65 Years | National Cancer Center, Korea |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
